mardi 31 mai 2016

Onco Actu du 31 mai 2016

2.6 Etiologie - Environnement

EU to propose shorter glyphosate license renewal: sources [Reuters]

4. Dépistage, diagnostic et pronostic

European Molecular Diagnostics in Cancer Testing Industry 2016 Market Research Report [ReportsnReports]

5.2.2 Pharma - Fusions & Acquisitions

Jazz Pharmaceuticals Nears Deal to Buy Celator for About $1.5 Billion [Wall Street Journal]

5.2.3 Pharma - économie

Roche and Novartis face off in biosimilar drug battle [Reuters]

5.3.4 Traitements - AMM (FDA, EMA)

Six medicines win backing for EU approval [PharmaTimes]

Roche’s subcutaneous formulation of MabThera receives approval in Europe for people with chronic lymphocytic leukaemia [Roche]

Roche's MabTherea shot gets EU OK for chronic lymphocytic leukemia [Reuters]

6.10 Politiques

Our cancer care is not giving us value for money [The Telegraph]

6.6 Publications

Why aren’t there more women in science? The industry structure is sexist [The Guardian]

6.9 Controverses

Cancer moonshot and slow-learners [The Mermaid's Tale]